LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Continente #
NA - Nord America 3899
EU - Europa 374
AF - Africa 193
AS - Asia 38
SA - Sud America 16
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4531
Nazione #
US - Stati Uniti d'America 3883
NG - Nigeria 193
FR - Francia 118
NL - Olanda 72
IT - Italia 54
GB - Regno Unito 43
DE - Germania 22
BE - Belgio 19
CA - Canada 14
CL - Cile 10
CN - Cina 10
FI - Finlandia 9
TR - Turchia 9
UA - Ucraina 8
IL - Israele 7
RO - Romania 7
RU - Federazione Russa 7
AU - Australia 6
BR - Brasile 5
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
AT - Austria 2
BD - Bangladesh 2
CH - Svizzera 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
PA - Panama 2
EE - Estonia 1
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
SE - Svezia 1
SI - Slovenia 1
Totale 4531
Città #
Chandler 1083
Wilmington 1052
San Mateo 403
Ann Arbor 337
Lawrence 204
Princeton 204
Benin City 193
Leawood 179
Paris 116
Fairfield 87
Boardman 86
Woodbridge 82
Amsterdam 56
London 41
Milan 23
Norwalk 23
Brussels 19
San Diego 18
Seattle 17
Toronto 11
Abbiategrasso 10
Hanover 10
Helsinki 9
Kocaeli 9
Ashburn 6
Monmouth Junction 6
Redmond 6
Beijing 5
Clearwater 5
Falls Church 5
Houston 4
São Paulo 4
Andover 3
Des Moines 3
Henderson 3
Novokuznetsk 3
Phoenix 3
Redwood City 3
Riverview 3
Apo 2
Canberra 2
Dhaka 2
Eden Prairie 2
Erbusco 2
Genoa 2
Kemerovo 2
Nanjing 2
New York 2
Palazzolo sull'Oglio 2
San Jose 2
Addison 1
Agrate Brianza 1
Almaty 1
Bitola 1
Cagayan de Oro 1
Chicago 1
Chisinau 1
Dearborn 1
Ferrara 1
Gunzenhausen 1
Haifa 1
Hebei 1
Hefei 1
Jacksonville 1
Kooralbyn 1
Las Vegas 1
Lima 1
Ljubljana 1
Los Angeles 1
Markham 1
Montreal 1
Pamplona 1
Portland 1
Raleigh 1
Reghin 1
Riyadh 1
Rome 1
Saint Paul 1
San Francisco 1
Santa Clara 1
Shenyang 1
Spring 1
Tallinn 1
Tenhult 1
Trieste 1
Warsaw 1
Winnipeg 1
Totale 4393
Nome #
G protein mutations in endocrine diseases 45
G-Protein and Signalling in Pituitary Tumours 40
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 40
Functional hypothalamic and drug-induced amenorrhea: an overview 40
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 40
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 40
A 2019 update on TSH-secreting pituitary adenomas 39
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 37
A potential catastrophic trap: an unusually presenting sellar lesion 36
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 36
Growth factors and human pituitary adenomas 36
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 36
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 36
Hormonal signaling and pituitary adenomas 35
Bone disorders associated with acromegaly: mechanisms and treatment 35
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 35
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 34
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 34
Genetics of pituitary tumors: Focus on G-protein mutations 33
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 33
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy) 33
Central hypothyroidism and growth hormone treatment : clinical care 32
cAMP in the pituitary: An old messenger for multiple signals 32
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 32
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 32
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 32
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 32
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 32
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 32
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 32
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 31
G protein abnormalities in pituitary adenomas 31
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 31
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 31
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 31
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 31
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 31
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 30
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 30
Central hypothyroidism - a neglected thyroid disorder 30
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 30
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 30
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 30
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 30
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 30
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 29
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed 29
Patients with macroprolactinaemia: clinical and radiological features 28
Mutational analysis of PRKAR1A and Gs alpha in sporadic adrenocortical tumors 28
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 28
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 28
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function 28
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 28
Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: Identification of one pancreatic ghrelinoma 28
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 27
Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells 27
Endoscopic expanded endonasal approach: preliminary experience with the new 3D endoscope 27
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks 27
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 27
An Unusual Case of Recurrent Autoimmune Hypophysitis 27
Inactivating and activating mutations of the Gs alpha gene 27
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 27
Pituitary incidentalomas 26
GNAS imprinting and pituitary tumors 26
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors 26
cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion 26
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 26
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 26
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 26
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 26
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 26
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 26
Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib 25
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 25
Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas 25
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 25
Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line 25
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 25
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 25
Clinically non-functioning pituitary incidentalomas: characteristics and natural history 25
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 24
Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells 24
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways 24
Genetic abnormalities of somatostatin receptors in pituitary tumors 24
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 24
Central hypothyroidism 24
GH Response to Oral Glucose Tolerance Test: A Comparison between Patients with Acromegaly and Other Pituitary Disorders 24
Pegvisomant in acromegaly: an update (vol 40, pg 577, 2017) 24
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 24
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 24
Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification 24
Eight-year follow-up of a child with a GH/prolactin-secreting adenoma : efficacy of pegvisomant therapy 24
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly 24
Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients 24
cAMP pathway and pituitary tumorigenesis 24
Evaluation of the ex vivo Effects of Tamoxifen on Adipose-Derived Stem Cells: A Pilot Study 24
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 23
Characterization of Intracellular Signaling Mediated by Human Somatostatin Receptor 5: Role of the DRY Motif and the Third Intracellular Loop 23
Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types 23
Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas 23
Totale 2924
Categoria #
all - tutte 25740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0000 00 00 0001
2020/20211831 624915 15624 252154 35217310197
2021/20221023 3168227 78 32133 15011424067
2022/20231837 448144307350 288267 330 0000
Totale 4692